doi: 10.3389/fneur.2026.1788148 Received 15 January 2026 Revised 16 February 2026 Accepted 23 February 2026 Published 07 April 2026 Volume 17 - 2026 Edited by Paul Chazot, Durham University, United Kingdom Reviewed by Li Baojian, Shaanxi University of Chinese Medicine, China Ayokunmi Akinduko, Landmark University, Nigeria Updates Copyright 2026 Okomolo Moto, Diapa Tchiengang, Kameni Njapdounke, Mbom, Mbeboh Savo, Aren Arsaa, Nezoumne, Ndjock and Bum
It contains a 40mg research formulation combining Retatrutide, BPC-157, and TB-500 in a precision pre-calibrated research pen
Pegylated arginase has potential arginine degradation and antitumor activity
Retrieved 23 February 2026
Some individuals have an immune response to these proteins, leading to inflammation and gut dysbiosis